Common Contracts
2 similar Bridge Loan Agreement contracts by Teva Pharmaceutical Industries LTD
BRIDGE LOAN AGREEMENT dated as of September 9, 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL FINANCE COMPANY B.V., as Borrowers, THE LENDERS PARTY HERETO FROM TIME TO TIME, BARCLAYS BANK PLC,...Bridge Loan Agreement • November 2nd, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Bridge Loan Agreement (this “Agreement”), dated as of September 9, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA PHARMACEUTICAL FINANCE COMPANY B.V., a Curaçao company registered under no. 98250 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao III”), the Additional Borrowers party hereto from time to time, the Lenders party hereto from time to time, BARCLAYS BANK PLC (the “Administrative Agent”), and BARCLAYS BANK PLC, as Documentation Agent (the “Documentation Agent”).
BRIDGE LOAN AGREEMENT dated as of June 13, 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL FINANCE COMPANY B.V., TEVA PHARMACEUTICAL FINANCE N.V., as Borrowers, THE LENDERS PARTY HERETO FROM TIME...Bridge Loan Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Bridge Loan Agreement (this “Agreement”), dated as of June 13, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA PHARMACEUTICAL FINANCE COMPANY B.V., a Curaçao company registered under no. 98250 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao III”), TEVA PHARMACEUTICAL FINANCE N.V., a Curaçao company registered under no. 86707 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao IV”), the Additional Borrowers party hereto from time to time, the Lenders party hereto from time to time, CITIBANK, N.A. (the “Administrative Agent”) and HSBC BANK PLC, as Documentation Agent (th
